Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation

American Journal of Pathology

Volumn 154, Issue 1, 1999, Pages 113-118

  An, Han Xiang ^a,b   Beckmann, Matthias W ^a   Reifenberger, Guido ^c   Bender, Hans G ^a   Niederacher, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Heinrich Heine Universität ^*

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL PROLIFERATION; DISEASE ASSOCIATION; DNA SEQUENCE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032919173     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65257-1     Document Type: Article

References (36)

1. Sherr CJ: Mammalian G1 cyclins. Cell 1993, 73:1059-1065
2. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 1994, 266:1821-1828
3. Hunter T, Pines J: Cyclins and cancer: II. Cyclin D and CDK inhibitors come of age. Cell 1994, 79:573-582
4. Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ: Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 1992, 71: 323-334
5. Xiong Y, Zhang H, Beach D: Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 1993, 7:1572-1583
6. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT: Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 1993, 53:5535-5541
7. Collins VP: Gene amplification in human gliomas. Glia 1995, 15:289-296
8. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP: Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 1994, 54:4299-4303
9. Wölfel T, Hauer M, Schneider J, Serrano M, Wàlfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Buschenfelde KH, Beach DA: p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995, 269:1281-1284
10. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993, 8:2127-2133
11. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994, 54:1812-1817
12. Lee EY, To H, Shew JY, Bookstein R, Scully P, Lee WH: Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988, 241:214-221
13. Lungberg C, Skoog L, Cavenee WK, Nordenskjöld M: Loss of heterozygosity in human ductal breast cancer indicates a recessive mutation on chromosome 13. Proc Natl Acad Sci USA 1987, 84:2372-2376
14. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995, 55:4525-4530
15. Geleick D, Müller H, Matter A, Torhorst J, Regenass U: Cytogenetics of breast cancer. Cancer Genet Cytogenet 1990, 46:217-229
16. Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zeillinger R, Rodriguez C, Theillet C: Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res 1997, 57:4360-4367
17. Sgambato A, Han EK, Zhang YJ, Moon RC, Santella RM, Weinstein IB: Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis 1995, 16:2193-2198
18. An HX, Niederacher D, Beckmann MW, Göhring UJ, Scharl A, Picard F, van Roeyen C, Schnurch H-G, Bender HG: ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues. Int J Cancer 1995, 64:291-297
19. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: I. the value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410
20. Beckmann MW, Niederacher D, Massenkeil G, Tutschek B, Beckmann A, Schenko G, Schnürch H-G, Bender HG: Expression analyses of epidermal growth factor receptor and HER-2/neu: no advantage of prediction of recurrence or survival in breast cancer patients. Oncology 1996, 53:441-447
21. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580
22. Volm M, Koomägi R, Rittgen W: Clinical implications of cyclins, cyclin-dependent kinase, RB and E2F1 in squamous-cell lung carcinoma. Int J Cancer 1998, 79:294-299
23. Cawkwell L, Lewis FA, Quirke P: Frequency of allele loss of DCC, p53, RB1, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 1993, 70:813-818
24. Niederacher D, Picard F, van Roeyen C, An HX, Bender HG, Beckmann MW: Pattern of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent labelled microsatellite analysis. Genes Chromosome Cancer 1997, 18:181-192
25. Ito Y, Kobayashi T, Takeda T, Nakano Y, Tamaki Y, Komoike Y, Wakasugi E, Shin E, Takatsuka Y, Kikkawa N, Matsuura N, Monden M: Expression of p16 and cyclin-dependent kinase 4 proteins in primary breast carcinomas. Oncology 1997, 54:508-515
26. Sasano H, Frost AR, Saitoh R, Taniyama Y, Nagura H, Matsunaga G, Takehana K, Kimura M, Silverberg SG: Immunolocalisation of cyclin D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma. Anticancer Res 1997, 17:3685-3690
27. He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R, Day RS 3rd, James CD: CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 1994, 54:5804-5807
28. Rollbrocker B, Waha A, Louis DN, Wiestler OD, von Deimling A: Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme. Acta Neuropathol 1996, 92:70-74
29. Zhang T, Nanney LB, Luongo C, Lamps L, Heppner KJ, DuBois RN, Beauchamp RD: Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res 1997, 57:169-175
30. Serrano M, Hannon GJ, Beach DA: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D1/CDK4. Nature 1993, 366:704-707
31. Maelandsmo GM, Florenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Borresen AL, Fodstad O: Involvement of the pRb/p16/cdk4/ cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. Br J Cancer 1996, 73:909-916
32. Schmidt EE, Ichimura K, Reifenberger G, Collins VP: CDKN2 (p16/ MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994, 54:6321-6324
33. Otterson GA, Kratzke RA, Coxon A, Kim YW, Kaye FJ: Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 1994, 9:3375-3378
34. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN: CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 1996, 56:150-153
35. Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH, Harris CC, Montesano R, Weinstein IB: Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 1993, 90:9026-9030
36. Xu L, Sgroi D, Sterner CJ, Beauchamp RL, Pinney DM, Keel S, Ueki K, Rutter JL, Buckler AJ, Louis DN, Gusella JF, Ramesh V: Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. Cancer Res 1994, 54:5262-5264